Informations générales (source: ClinicalTrials.gov)
French Cohort of Myocardial Infarction Evaluation
Observational
Assistance Publique - Hôpitaux de Paris (Voir sur ClinicalTrials)
mars 2019
mars 2049
18 septembre 2025
Over the last two decades, considerable progress has been made in the management of Acute
Myocardial Infarction (AMI), both in the acute phase and in monitoring beyond the
hospital phase. Nevertheless, the evolution of care practices and their impact on the
mid- and long-term prognosis of patients admitted to the intensive care unit for acute
myocardial infarction remain relatively little studied exhaustively.
The aim of this study is to assess the profile of AMI patients, their management and
follow-up in order to evaluate the relationship between these factors and outcomes.
Etablissements
Critères
Tous
Inclusion Criteria:
- Myocardial infarction (MI) within 48h of symptom onset, characterized by the typical
increased or fall of troponin (or CPKMB) associated with at least one of the
following elements :
- Symptoms compatible with myocardial ischemia
- Appearance of pathological Q waves
- ST- T changes compatible with myocardial ischemia (ST segment elevation or
depression, T-wave inversion)
- Written consent.
- Covered by French medical insurance ("Sécurité Sociale")
- Myocardial infarction (MI) within 48h of symptom onset, characterized by the typical
increased or fall of troponin (or CPKMB) associated with at least one of the
following elements :
- Symptoms compatible with myocardial ischemia
- Appearance of pathological Q waves
- ST- T changes compatible with myocardial ischemia (ST segment elevation or
depression, T-wave inversion)
- Written consent.
- Covered by French medical insurance ("Sécurité Sociale")
- Iatrogenic MI defined as MI occurring within 48h of a therapeutic procedure
- AMI diagnosis invalidated in favor of another diagnosis